ATHE

ALTERITY THERAPEUTICS LTD

ATHE·02155X205·US·ADR·Healthcare - Biotechnology-13D/G

ATHE (ALTERITY THERAPEUTICS LTD) is held by 10 institutional investors as of Q1 2026. Largest holders: HB Wealth Management, LLC ($203,441), MORGAN STANLEY ($203,170), GREENLEAF TRUST ($111,360). Net institutional sentiment: Bearish.

10
Holders
Avg rating(4 Elite)
$620,495
Total Value
17% (11)
Fund Consensus
1 buying - 5 selling

No verdict yet — fewer than 2 funds hold ATHE.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
58,460$203,4410.0%+37.82%
0
Decreased
58,382(-8.3%)$203,1700.0%+110.25%
0
Unchanged
32,000$111,3600.0%+38.00%
0
Increased
20,077(+19.4%)$71,4740.0%+40.96%
17
Decreased
6,809(-1.4%)$23,6950.0%+55.40%
0
Decreased
1,970(-7.4%)$7,0100.0%+59.89%
0
Decreased
68(-16.1%)$2400.0%+10.21%
0
Unchanged
22$800.0%+37.82%
0
Unchanged
6$210.0%-54.37%
0
Unchanged
1$40.0%+308.27%
0
Exited
0(-100.0%)$30.0%-13.71%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used